Kazuo Umezawa

13.2k total citations · 1 hit paper
425 papers, 11.0k citations indexed

About

Kazuo Umezawa is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Kazuo Umezawa has authored 425 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 211 papers in Molecular Biology, 124 papers in Cancer Research and 91 papers in Oncology. Recurrent topics in Kazuo Umezawa's work include NF-κB Signaling Pathways (99 papers), Bioactive Compounds and Antitumor Agents (32 papers) and Immune Response and Inflammation (32 papers). Kazuo Umezawa is often cited by papers focused on NF-κB Signaling Pathways (99 papers), Bioactive Compounds and Antitumor Agents (32 papers) and Immune Response and Inflammation (32 papers). Kazuo Umezawa collaborates with scholars based in Japan, United States and China. Kazuo Umezawa's co-authors include Masaya Imoto, Francisco E. Baralle, Alberto R. Kornblihtt, Karen Vibe‐Pedersen, Siro Simizu, TOMIO TAKEUCHI, HIROSHI NAGANAWA, Minoru Takada, Ryouichi Horie and Jun‐ichiro Inoue and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kazuo Umezawa

419 papers receiving 10.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene.

1985 583 citations Kazuo Umezawa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuo Umezawa Japan	51	5.3k	2.4k	2.1k	2.1k	1.1k	425	11.0k
Robert Newton United States	67	4.6k 0.9×	2.0k 0.8×	3.0k 1.5×	3.6k 1.8×	1.5k 1.3×	268	13.3k
Jack L. Arbiser United States	62	5.6k 1.1×	1.5k 0.6×	2.3k 1.1×	1.7k 0.8×	572 0.5×	246	12.6k
Ikuo Saiki Japan	58	5.5k 1.0×	1.6k 0.7×	3.4k 1.6×	2.6k 1.2×	1.1k 1.0×	333	12.1k
John DiGiovanni United States	56	6.6k 1.2×	3.1k 1.3×	3.5k 1.7×	2.2k 1.1×	526 0.5×	322	12.6k
Joël Raingeaud France	17	7.9k 1.5×	1.7k 0.7×	2.1k 1.0×	1.7k 0.8×	542 0.5×	23	11.0k
Lufen Chang United States	21	7.2k 1.4×	2.0k 0.8×	1.8k 0.9×	2.3k 1.1×	566 0.5×	27	12.2k
Jerry L. Adams United States	38	5.6k 1.1×	1.1k 0.5×	2.1k 1.0×	1.9k 0.9×	662 0.6×	73	9.6k
Sebastian Wesselborg Germany	56	7.2k 1.4×	1.5k 0.6×	1.6k 0.8×	3.9k 1.9×	711 0.6×	136	13.4k
Faustino Mollinedo Spain	55	5.8k 1.1×	1.1k 0.5×	1.1k 0.5×	1.6k 0.8×	512 0.5×	207	9.6k
Anning Lin United States	55	10.5k 2.0×	4.0k 1.7×	2.8k 1.3×	3.3k 1.6×	599 0.5×	89	15.5k

Countries citing papers authored by Kazuo Umezawa

Since Specialization

Citations

This map shows the geographic impact of Kazuo Umezawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuo Umezawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuo Umezawa more than expected).

Fields of papers citing papers by Kazuo Umezawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuo Umezawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuo Umezawa. The network helps show where Kazuo Umezawa may publish in the future.

Co-authorship network of co-authors of Kazuo Umezawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuo Umezawa. A scholar is included among the top collaborators of Kazuo Umezawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuo Umezawa. Kazuo Umezawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wakatsuki, Akihiko, et al.. (2023). Inhibitory effects of estetrol on the invasion and migration of immortalized human endometrial stromal cells. Endocrine Journal. 71(2). 199–206. 3 indexed citations

Matsushita, Hiroshi, Yuka Takeuchi, Jun Ma, et al.. (2023). Inhibition of MLCK‑mediated migration and invasion in human endometriosis stromal cells by NF‑κB inhibitor DHMEQ. Molecular Medicine Reports. 28(2). 6 indexed citations

Yamanaka, Takahiro, Norifumi Harimoto, Takehiko Yokobori, et al.. (2021). Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein–coupled Receptor 68. Molecular Cancer Therapeutics. 20(6). 1019–1028. 22 indexed citations

Nakano, Yutaka, Sachiko Matsuda, Osamu Itano, et al.. (2021). Intravenous Administration of Dehydroxymethylepoxyquinomicin With Polymer Enhances the Inhibition of Pancreatic Carcinoma Growth in Mice. Anticancer Research. 41(12). 6003–6012.

Matsuse, Michiko, Yuka Nakazawa, Tomoo Ogi, et al.. (2019). JAK/STAT3 and NF-κB Signaling Pathways Regulate Cancer Stem-Cell Properties in Anaplastic Thyroid Cancer Cells. Thyroid. 29(5). 674–682. 46 indexed citations

Tezuka, Takehiko, Akinobu Ota, Sivasundaram Karnan, et al.. (2018). The plant alkaloid conophylline inhibits matrix formation of fibroblasts. Journal of Biological Chemistry. 293(52). 20214–20226. 7 indexed citations

Koide, Naoki, et al.. (2017). MOLECULAR DESIGN OF SUGAR-FREE MIGRACIN ANALOG MIGRACINAL THAT INHIBITS OVARIAN CANCER CELL MIGRATION AND INVASION. SHILAP Revista de lepidopterología. 7(4). 16–20. 2 indexed citations

Burgess, Joshua T., Emma Bolderson, Mark N. Adams, et al.. (2016). Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response. QUT ePrints (Queensland University of Technology). 2 indexed citations

Brassesco, María Sol, Julia Alejandra Pezuk, Jaqueline Carvalho de Oliveira, et al.. (2013). Activator Protein-1 Inhibition by 3-[(Dodecylthiocarbonyl)Methyl]-Glutamaride Impairs Invasion and Radiosensitizes Osteosarcoma Cells In Vitro. Cancer Biotherapy and Radiopharmaceuticals. 28(4). 351–358. 1 indexed citations

10.

Hinohara, Kunihiko, Seiichiro Kobayashi, Hajime Kanauchi, et al.. (2012). ErbB receptor tyrosine kinase/NF-κB signaling controls mammosphere formation in human breast cancer. Proceedings of the National Academy of Sciences. 109(17). 6584–6589. 86 indexed citations

11.

Niwa, Yuki, Takehiro Suzuki, Naoshi Dohmae, Kazuo Umezawa, & Siro Simizu. (2012). Determination of cathepsin V activity and intracellular trafficking by N‐glycosylation. FEBS Letters. 586(20). 3601–3607. 40 indexed citations

12.

Kojima, Ikuho, Izumi Takei, Kazuo Umezawa, et al.. (2010). Rac1 regulates glucose-induced insulin secretion through the modulation of cytoskeletal organization in beta cells. Endocrine Journal. 57. 386. 1 indexed citations

13.

Tsukamoto, Nobuo, et al.. (2009). Impairment of Plasmacytoid Dendritic Cells for IFN Production by the Ligand for Immunoglobulin-Like Transcript 7 Expressed on Human Cancer Cells. Clinical Cancer Research. 15(18). 5733–5743. 25 indexed citations

14.

Murohashi, Michiko, Kunihiko Hinohara, Masahiko Kuroda, et al.. (2009). Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells. British Journal of Cancer. 102(1). 206–212. 74 indexed citations

15.

Mitsutake, Norisato, Masahiro Nakashima, Vladimir Saenko, et al.. (2008). DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts. Journal of Dermatological Science. 51(3). 171–180. 26 indexed citations

16.

Suzuki, Tomomi, Kenichiro Yamashita, Shinya Ueki, et al.. (2008). The Novel NF-κB Inhibitor, Dehydroxymethylepoxyquinomicin, Prevents Local and Remote Organ Injury Following Intestinal Ischemia/Reperfusion in Rats. Journal of Surgical Research. 149(1). 69–75. 37 indexed citations

17.

Kimura, Yusuke, Kosuke Watari, Abbas Fotovati, et al.. (2007). Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Science. 98(12). 2009–2018. 108 indexed citations

18.

Ui, Hideaki, Masaya Imoto, & Kazuo Umezawa. (1995). Inhibition of Phosphatidylinositol-specific Phospholipase C Activity by Fluvirucin B2.. The Journal of Antibiotics. 48(5). 387–390. 14 indexed citations

19.

Imoto, Masaya, et al.. (1994). Enhancement of CDP-DG:Inositol Transferase Activity in src- and erbB2-Transformed Cells. Experimental Cell Research. 212(1). 151–154. 6 indexed citations

20.

Atsumi, Shinichiro, et al.. (1993). Accumulation of Tissue Glucosylsphingosine in Gaucher-like Mouse Induced by the Glucosylceramidase Inhibitor Cyclophellitol. Archives of Biochemistry and Biophysics. 304(1). 302–304. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact